Drug Database
L02 ENDOCRINE THERAPY
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- L02AA01 diethylstilbestrol
- L02AB01 megestrol
- L02AB02 medroxyprogesterone
- L02AE01 buserelin
- L02AE02 leuprorelin
- L02AE03 goserelin
- L02AE04 triptorelin
- L02BA01 tamoxifen
- L02BA02 toremifene
- L02BA03 fulvestrant
- L02BB01 flutamide
- L02BB03 bicalutamide
- L02BB04 enzalutamide
- L02BB05 apalutamide
- L02BB06 darolutamide
- L02BG03 anastrozole
- L02BG04 letrozole
- L02BG06 exemestane
- L02BX02 degarelix
- L02BX03 abiraterone
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).